Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 16,540,000 | 12,726,000 | 8,454,000 | 4,457,000 | 15,409,000 |
| Depreciation Amortization | 3,754,000 | 2,699,000 | 1,791,000 | 891,000 | 3,746,000 |
| Income taxes - deferred | -341,000 | 215,000 | 115,000 | 393,000 | -270,000 |
| Accounts receivable | -1,076,000 | -746,000 | -1,102,000 | -390,000 | -415,000 |
| Other Working Capital | -1,784,000 | -4,141,000 | -4,088,000 | -3,839,000 | 1,647,000 |
| Other Operating Activity | 1,674,000 | 1,361,000 | 1,583,000 | 677,000 | -548,000 |
| Operating Cash Flow | $18,767,000 | $12,114,000 | $6,753,000 | $2,189,000 | $19,569,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,959,000 | -1,260,000 | -711,000 | -614,000 | 1,000 |
| Net Acquisitions | -4,509,000 | -4,050,000 | -730,000 | -5,000 | -954,000 |
| Purchase Of Investment | -33,950,000 | -27,677,000 | -17,511,000 | -10,062,000 | -40,828,000 |
| Sale Of Investment | 35,780,000 | 30,437,000 | 18,775,000 | 9,145,000 | 34,149,000 |
| Other Investing Activity | -123,000 | -37,000 | -38,000 | -1,000 | -103,000 |
| Investing Cash Flow | $-4,761,000 | $-2,587,000 | $-215,000 | $-1,537,000 | $-7,735,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 111,000 | 149,000 | 118,000 | 95,000 | 2,416,000 |
| Debt Issued | 12,004,000 | 11,951,000 | 11,951,000 | 7,435,000 | 75,000 |
| Debt Repayment | -2,223,000 | -953,000 | -936,000 | -14,000 | -68,000 |
| Common Stock Issued | 1,189,000 | 1,112,000 | 929,000 | 510,000 | 1,005,000 |
| Common Stock Repurchased | -8,979,000 | -6,954,000 | -4,751,000 | -2,389,000 | -5,290,000 |
| Dividend Paid | -8,621,000 | -6,451,000 | -4,266,000 | -2,069,000 | -8,173,000 |
| Other Financing Activity | -2,032,000 | -3,941,000 | -4,687,000 | -4,172,000 | -1,101,000 |
| Financing Cash Flow | $-8,551,000 | $-5,087,000 | $-1,642,000 | $-604,000 | $-11,136,000 |
| Exchange Rate Effect | -215,000 | 33,000 | 12,000 | 81,000 | -1,489,000 |
| Beginning Cash Position | 13,732,000 | 13,732,000 | 13,732,000 | 13,732,000 | 14,523,000 |
| End Cash Position | 18,972,000 | 18,205,000 | 18,640,000 | 13,861,000 | 13,732,000 |
| Net Cash Flow | $5,240,000 | $4,473,000 | $4,908,000 | $129,000 | $-791,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 18,767,000 | 12,114,000 | 6,753,000 | 2,189,000 | 19,569,000 |
| Capital Expenditure | -3,226,000 | -2,133,000 | -1,396,000 | -639,000 | -3,463,000 |
| Free Cash Flow | 15,541,000 | 9,981,000 | 5,357,000 | 1,550,000 | 16,106,000 |